Antidote Health
Series A in 2023
Antidote Health is a telemedicine company that offers an AI-driven health platform aimed at enhancing the medical treatment process for patients. The platform streamlines patient screening and supports doctors in their decision-making, minimizing administrative burdens and improving the quality of interactions between healthcare providers and patients. By integrating features that address social health aspects, Antidote Health fosters a positive ripple effect within communities, ultimately benefiting patients, doctors, and their families. The company is dedicated to making premium healthcare accessible and affordable for all, ensuring a comprehensive approach to health that extends beyond individual care.
MDI Health Technologies
Series A in 2023
Founded in 2018, MDI Health Technologies Ltd develops an AI-based personalized medication management system. It collects patient data, predicts medication risks and efficacies, suggests actions, and monitors treatments, serving patients, doctors, and clinical pharmacologists.
Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.
Behavidence
Seed Round in 2022
Behavidence is a company that specializes in mental health diagnosis and monitoring through the use of artificial intelligence. It focuses on detecting subtle changes in phone usage patterns to identify and monitor conditions such as Depression, Anxiety, Stress, ADHD, and Postpartum Depression. By employing digital phenotyping and machine learning algorithms, Behavidence provides high-accuracy tools for evaluating the onset, progression, and potential relapse of these mental health conditions. Its products have been adopted by various health organizations, health technology firms, and governmental entities worldwide, enabling effective screening, remote monitoring, and detection of comorbidities. The platform prioritizes user privacy, imposes no burden on respondents, and offers real-time feedback, thus enhancing therapeutic interventions and improving overall quality of life for users and caregivers.
Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.
Helping Hand
Seed Round in 2021
Helping Hand is a Polish mental health platform that provides online psychological support. The service combines personalized content with interactive sessions conducted by therapists, enabling users to receive tailored counseling for conditions such as depression, anxiety, and stress. The platform gives access to a vetted network of experienced psychotherapists and their calendars, supporting scheduling and ongoing care.
Amkiri
Venture Round in 2021
Amkiri develops a new beauty category that combines fragrance with visual expression to enable multisensory self-expression. It manufactures patented scented ink for skin application using specialized applicators. The fragrance ink is alcohol-free, vegan, and cruelty-free, designed for extended wear and removable with soap and water, enabling users to express creativity in their daily beauty rituals.
X-trodes
Seed Round in 2021
X-trodes develops scalable wireless electronic technology and analytics for biopotential signals, enabling advanced electrophysiological monitoring. Its solution combines wearable hardware with automated, high-resolution analysis to support clinical evaluation and treatment across brain, eye, muscle, and heart signals. The technology is designed to track physiological activity during sleep and everyday tasks, providing objective measurements that can inform medical decisions and help improve patients’ quality of life. By integrating sensors and analytics in a cohesive platform, X-trodes aims to make continuous biopotential monitoring practical in routine healthcare settings, offering clinicians and patients insights into neural, ocular, muscular, and cardiovascular health through a single, scalable system.
Behavidence
Pre Seed Round in 2021
Behavidence is a company that specializes in mental health diagnosis and monitoring through the use of artificial intelligence. It focuses on detecting subtle changes in phone usage patterns to identify and monitor conditions such as Depression, Anxiety, Stress, ADHD, and Postpartum Depression. By employing digital phenotyping and machine learning algorithms, Behavidence provides high-accuracy tools for evaluating the onset, progression, and potential relapse of these mental health conditions. Its products have been adopted by various health organizations, health technology firms, and governmental entities worldwide, enabling effective screening, remote monitoring, and detection of comorbidities. The platform prioritizes user privacy, imposes no burden on respondents, and offers real-time feedback, thus enhancing therapeutic interventions and improving overall quality of life for users and caregivers.
Amai Proteins
Funding Round in 2021
Amai Proteins develops novel sweet protein ingredients intended as healthy sugar substitutes for the food and beverage industry. By applying agile integrative computational protein design and precision fermentation, the company creates hyper-sweet designer proteins that are tasty, stable, sustainable, food-compatible, and cost-effective. These ingredients are designed for broad mass-market use and support plant- and dairy-based protein products.
Antidote Health
Pre Seed Round in 2021
Antidote Health is a telemedicine company that offers an AI-driven health platform aimed at enhancing the medical treatment process for patients. The platform streamlines patient screening and supports doctors in their decision-making, minimizing administrative burdens and improving the quality of interactions between healthcare providers and patients. By integrating features that address social health aspects, Antidote Health fosters a positive ripple effect within communities, ultimately benefiting patients, doctors, and their families. The company is dedicated to making premium healthcare accessible and affordable for all, ensuring a comprehensive approach to health that extends beyond individual care.
Using computer vision, Sency builds the brain of movement in order to drive people towards an active and healthy life.
Founded in 2019, Sency created the See.Know.Guide (SKG) methodology. Using a mobile device camera, our unique algorithm understands movement thanks to massive data collection and expert knowledge. As a result, it provides real-time guidance and personalized plans. Sency's brain is constantly learning to serve with accurate actionable insights.
Our technology is running on the Edge. All data is kept on the client’s device: no streaming to the cloud means no latency, no recording, and no chance of a breach of privacy.
As a user-centric approach, Sency deploys interactive experiences on consumer devices only - no hardware required. Our first applications based on our core technology are the “Sency Health” and the “WODProof” apps.
From health to fitness, Sency already helped 450,000 people worldwide to achieve their physical goals and keep continuing.
Amkiri
Venture Round in 2020
Amkiri develops a new beauty category that combines fragrance with visual expression to enable multisensory self-expression. It manufactures patented scented ink for skin application using specialized applicators. The fragrance ink is alcohol-free, vegan, and cruelty-free, designed for extended wear and removable with soap and water, enabling users to express creativity in their daily beauty rituals.
Amai Proteins
Seed Round in 2020
Amai Proteins develops novel sweet protein ingredients intended as healthy sugar substitutes for the food and beverage industry. By applying agile integrative computational protein design and precision fermentation, the company creates hyper-sweet designer proteins that are tasty, stable, sustainable, food-compatible, and cost-effective. These ingredients are designed for broad mass-market use and support plant- and dairy-based protein products.